Item 8.01.  Other Events

Applied Therapeutics, Inc. (the "Company") currently intends to hold its first Annual Meeting of Stockholders (the "Annual Meeting") on June 4, 2020, at a time and location to be determined and specified in the Company's proxy statement related to the Annual Meeting. Under the SEC's rules, stockholders who have continuously held at least $2,000 in market value, or 1%, of the common stock of the Company for at least one year by the date they submit the proposal are eligible to submit a proposal. The Company has set the deadline for submission of proposals to be included in its proxy materials for the Annual Meeting as of March 6, 2020. Accordingly, in order for a stockholder proposal to be considered for inclusion in the Company's proxy materials for the Annual Meeting, the proposal must be received by the Secretary of the Company at the Company's offices at 545 5th Avenue, Suite 1400, New York, NY 10017, on or before such date, and comply with the procedures and requirements set forth in Rule 14a-8 under the Exchange Act.

In accordance with the advance notice requirements contained in the Amended and Restated Bylaws of the Company (the "Bylaws"), for director nominations or other business to be brought before the Annual Meeting by a stockholder, other than Rule 14a-8 proposals described above, written notice must be delivered to the Secretary of the Company no later than March 6, 2020. These stockholder notices also must comply with the requirements of the Bylaws and will not be effective otherwise.

© Edgar Online, source Glimpses